Cite
MLA Citation
C. Mata Martínez et al.. “AB0990 Rituximab in Chronic Autoimmune Rheumatic Diseases: Safety and Clinical Profile after 12 and 24 Months of Follow-Up.” Annals of the rheumatic diseases, vol. 75, n.d., pp. 1239–1240. http://access.bl.uk/ark:/81055/vdc_100135161102.0x000053